comprehensive -WSS

comprehensive

author：knowledge 2025-10-01 00:58:37 - browse：973

In this photo illustration, Farxiga, Xarelto, Entresto, and Eliquis are made available to customers at the New City Halsted Pharmacy on August 29, 2023 in Chicago, Illinois. These are 4 of 10 prescription drugs that will be subject to Medicare price negotiations under the Inflation Reduction Act. The other drugs include Jardiance, Enbrel, Januvia, Imbruvica, Stelara and Fiasp. — Scott Olson/Getty Images

WASHINGTON — The Biden administration is making its opening offers to pharmaceutical companies in its brand-new Medicare drug price negotiation program on Thursday, administration officials said. And that’s about all they said.

The offers will not be made public unless a manufacturer chooses to publicly disclose information about the talks, a senior administration official said. Companies have until March 2 to either accept the government’s offer or propose a counteroffer. The Biden administration will publish the final prices by Sept. 1 of this year after the negotiation process ends.

The negotiated prices won’t take effect until 2026.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Cord blood banking comes at a high cost to babies

focus

WSS

See how much Covid

Flagship, Pfizer team up in deal worth up to $7 billion

Johnson & Johnson sues to stop Medicare negotiation

Biden administration sends mixed signals on US soldier who crossed into North Korea

NIH documents show early flaws of $1.6 billion long Covid program

Phoenix breaks record with 19 consecutive days above 110 degrees Fahrenheit

entertainment

comprehensive

focus

Apple is now the first public company to be valued at $3 trillion

Biden administration sends mixed signals on US soldier who crossed into North Korea

Hepatitis C has a cure — but many Americans still lack access to it

Britain’s MI6 chief says his spies are using AI to disrupt flow of weapons to Russia

Heart attack and stroke risk calculators need revising

ASCO: Palliative care found as helpful given virtually as in person

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Ultragenyx gene therapy for rare liver ailment succeeds in late

Jerome Adams on the need for new antivirals for Covid

ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

focus

FDA's Pazdur wants cancer trials to range beyond China alone

Let's speed up science by embracing open access publishing

Ultragenyx gene therapy for rare liver ailment succeeds in late

At ASCO, pharma leaders speak of advances in 'smart bomb' drugs

US soldier in North Korean custody after crossing DMZ line

Ionis drug prevents swelling attacks due to hereditary angioedema

Wikipedia

focus

entertainment

leisure time